Neos Therapeutics

Teva and Neos settle over Cotempla patent dispute
Pharmaforum
Thu, 12/27/18 - 10:17 pm
Teva Pharmaceutical
Neos Therapeutics
generics
patents
ADHD
Cotempla XR-ODT
PDL gets aggressive with an offer to buy out Neos Therapeutics
Endpoints
Thu, 10/26/17 - 10:44 am
PDL Biopharma
Neos Therapeutics
M&A
Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval
Xconomy
Tue, 06/20/17 - 08:57 am
Neos Therapeutics
ADHD
FDA
Cotempla XR-ODT